Table 1.
Baseline characteristics (n = 24)
| All patients (n) % | |
|---|---|
| Age (years) | 80 ± 7 |
| Female | (14) 58 |
| BMI (kg/m2) | 27 ± 4 |
| Logistic EuroSCORE (%) | 25 ± 12 |
| EuroSCORE II (%) | 5 ± 5 |
| STS score (%) | 5 ± 3 |
| NYHA class | |
| II | (4) 17 |
| III | (18) 75 |
| IV | (2) 18 |
| LVEF | |
| >50 | (20) 83 |
| 31–50 | (3) 13 |
| <30 | (1) 4 |
| CAD | (15) 63 |
| Myocardial infarction | (4) 17 |
| CABG | (9) 38 |
| Stroke | (5) 21 |
| PAD | (10) 42 |
| PHT | (6) 25 |
| COPD | (5) 21 |
| Diabetes mellitus | (7) 29 |
| CKI | (2) 8 |
| Atrial fibrillation | (7) 29 |
| Permanent pacemaker | (2) 8 |
| Medication | |
| Aspirin | (16) 67 |
| Coumadin | (7) 29 |
| Clopidogrel | (6) 25 |
| Ticagrelor | (0) 0 |
| Prasugrel | (2) 8 |
| Dipyridamole | (3) 13 |
BMI, Body mass index; CABG, coronary artery bypass graft; CAD, coronary artery disease; CKI, chronic kidney injury; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; PAD, peripheral artery disease; PHT, pulmonary hypertension; STS, Society of Thoracic Surgeons